EGM
MDCO

Engineers Gate Manager’s Medicines Co MDCO Stock Holding History

Engineers Gate Manager’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-36,375
Closed -$1.38M – 859
2015
Q3 		$1.38M Buy
+36,375
New +$1.28M 0.12% 293

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Engineers Gate Manager's MDCO Position: Q4 2015 in Review

Engineers Gate Manager sold out of Medicines Co (MDCO) in Q4 2015, closing a stake of 36,375 shares — an estimated $1.38M sold.

Engineers Gate Manager first reported a position in MDCO in Q3 2015 and held it in 1 quarter. The position peaked at $1.38M in Q3 2015. 190 funds tracked by Wall St. Rank hold MDCO as of Q4 2015.

  • Engineers Gate Manager reported no remaining Medicines Co position as of Q4 2015 after selling out during the quarter.
  • Engineers Gate Manager sold 36,375 Medicines Co shares in Q4 2015, an estimated $1.38M.
  • Engineers Gate Manager first reported a position in Medicines Co in Q3 2015 and held it in 1 quarter.
  • Engineers Gate Manager's Medicines Co position peaked at $1.38M in Q3 2015.
  • 190 funds tracked by Wall St. Rank held Medicines Co as of Q4 2015.

Based on Engineers Gate Manager's 13F filing for Q4 2015, filed 5 Feb 2016.